Injective Teams Up with LI.FI for Seamless Trading Across Multiple Assets
Injective has integrated its platform with LI.FI to enable seamless trading of various assets. This integration will allow users to access a wide range of financial products, including US Stocks, ETFs, and Options, Indonesian Stocks, Crypto Assets, Digital Financial Asset Derivatives, Mutual Funds, and Gold.
The partnership between Injective and LI.FI is significant as it provides users with a single platform to trade multiple assets. This integration is made possible through the collaboration of various parties, including PT Bumi Santosa Cemerlang, PT PG Berjangka, PT Sarana Santosa Sejati, PT Pluang Maju Sekuritas, and PT ICDX Logistik Berikat.
It's worth noting that all investments involve risks, and the possibility of a loss in investment value. Users are advised to carefully evaluate their investment decisions before engaging with any financial products offered through this platform.